Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Tax Provisions: 2017-2025

Historic Tax Provisions for Autolus Therapeutics (AUTL) over the last 7 years, with Sep 2025 value amounting to $532,000.

  • Autolus Therapeutics' Tax Provisions rose 2318.18% to $532,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 11158.54%. This contributed to the annual value of $1.5 million for FY2024, which is 8142.11% up from last year.
  • Autolus Therapeutics' Tax Provisions amounted to $532,000 in Q3 2025, which was up 34.01% from $397,000 recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Tax Provisions high stood at $5.4 billion for Q3 2021, and its period low was -$17.4 million during Q4 2021.
  • Over the past 3 years, Autolus Therapeutics' median Tax Provisions value was $40,000 (recorded in 2023), while the average stood at $423,818.
  • Over the last 5 years, Autolus Therapeutics' Tax Provisions had its largest YoY gain of 68,367.90% in 2021, and its largest YoY loss of 347.34% in 2021.
  • Quarterly analysis of 5 years shows Autolus Therapeutics' Tax Provisions stood at -$17.4 million in 2021, then soared by 212.58% to $19.6 million in 2022, then tumbled by 100.12% to -$24,000 in 2023, then surged by 6,191.67% to $1.5 million in 2024, then skyrocketed by 2,318.18% to $532,000 in 2025.
  • Its last three reported values are $532,000 in Q3 2025, $397,000 for Q2 2025, and $2.2 million during Q1 2025.